Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 24% ± 8% | |
hematopoietic precursor cell | 3 studies | 19% ± 3% | |
GABAergic neuron | 3 studies | 23% ± 4% | |
glutamatergic neuron | 3 studies | 30% ± 5% | |
dendritic cell | 3 studies | 25% ± 5% | |
transit amplifying cell | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1373.12 | 1445 / 1445 | 100% | 43.54 | 183 / 183 |
ovary | 100% | 1034.73 | 180 / 180 | 100% | 45.49 | 430 / 430 |
stomach | 100% | 1115.87 | 359 / 359 | 100% | 41.85 | 286 / 286 |
breast | 100% | 1394.72 | 459 / 459 | 100% | 50.19 | 1117 / 1118 |
intestine | 100% | 1403.25 | 966 / 966 | 100% | 45.49 | 526 / 527 |
bladder | 100% | 1308.19 | 21 / 21 | 100% | 51.39 | 503 / 504 |
uterus | 100% | 1344.09 | 170 / 170 | 100% | 57.55 | 458 / 459 |
prostate | 100% | 1103.02 | 245 / 245 | 100% | 30.61 | 500 / 502 |
brain | 100% | 941.56 | 2631 / 2642 | 100% | 38.48 | 705 / 705 |
skin | 100% | 2106.30 | 1809 / 1809 | 100% | 52.23 | 470 / 472 |
liver | 100% | 852.70 | 225 / 226 | 100% | 24.75 | 406 / 406 |
thymus | 100% | 1363.88 | 653 / 653 | 100% | 40.62 | 602 / 605 |
lung | 99% | 1218.17 | 574 / 578 | 100% | 47.87 | 1155 / 1155 |
pancreas | 100% | 789.75 | 327 / 328 | 99% | 32.26 | 177 / 178 |
kidney | 100% | 1092.43 | 89 / 89 | 99% | 27.27 | 892 / 901 |
adrenal gland | 100% | 1730.50 | 258 / 258 | 97% | 27.18 | 224 / 230 |
adipose | 100% | 1359.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 73.67 | 29 / 29 |
spleen | 100% | 1612.59 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.16 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.45 | 1 / 1 |
blood vessel | 100% | 1146.78 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1008.62 | 800 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 41.69 | 78 / 80 |
heart | 95% | 801.98 | 819 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 1650.83 | 880 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1900087 | Biological process | positive regulation of G1/S transition of mitotic cell cycle |
GO_0006398 | Biological process | mRNA 3'-end processing by stem-loop binding and cleavage |
GO_0180010 | Biological process | co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway |
GO_0031124 | Biological process | mRNA 3'-end processing |
GO_0005847 | Cellular component | mRNA cleavage and polyadenylation specificity factor complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0004534 | Molecular function | 5'-3' RNA exonuclease activity |
GO_0004521 | Molecular function | RNA endonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | CPSF3 |
Protein name | CPSF3 protein Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73) Cleavage and polyadenylation specific factor 3 |
Synonyms | CPSF73 hCG_1784298 |
Description | FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre-mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. Has endonuclease activity, and functions as an mRNA 3'-end-processing endonuclease . Also involved in the histone 3'-end pre-mRNA processing . U7 snRNP-dependent protein that induces both the 3'-endoribonucleolytic cleavage of histone pre-mRNAs and acts as a 5' to 3' exonuclease for degrading the subsequent downstream cleavage product (DCP) of mature histone mRNAs. Cleavage occurs after the 5'-ACCCA-3' sequence in the histone pre-mRNA leaving a 3'hydroxyl group on the upstream fragment containing the stem loop (SL) and 5' phosphate on the downstream cleavage product (DCP) starting with CU nucleotides. The U7-dependent 5' to 3' exonuclease activity is processive and degrades the DCP RNA substrate even after complete removal of the U7-binding site. Binds to the downstream cleavage product (DCP) of histone pre-mRNAs and the cleaved DCP RNA substrate in a U7 snRNP dependent manner. Required for entering/progressing through S-phase of the cell cycle . Required for the selective processing of microRNAs (miRNAs) during embryonic stem cell differentiation via its interaction with ISY1 (By similarity). Required for the biogenesis of all miRNAs from the pri-miR-17-92 primary transcript except miR-92a (By similarity). Only required for the biogenesis of miR-290 and miR-96 from the pri-miR-290-295 and pri-miR-96-183 primary transcripts, respectively (By similarity). . |
Accessions | G5E9W3 ENST00000238112.8 C9JZH6 Q9UKF6 ENST00000475482.5 ENST00000460593.1 Q05BZ5 |